Bempegaldesleukin
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Bempegaldesleukin, covering 2021-10-14 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma. [Phase 2]